Los linfocitos T gamma-delta activados en condiciones Th1 expresan interferon gamma, mientras que los que son estimulados por células Th17, producen IL-17. Estos y otros resultados aparecen en Sun D, Chan N, Shao H, Born WK, Kaplan HJ. γδ T Cells Activated in Different Inflammatory Environments Are Functionally Distinct. J Immunol January 31, 2022, ji2100967; DOI: https://doi.org/10.4049/jimmunol.2100967.
En la sección: Inflamación, Inmunidad de mucosas, Inmunidad innata, Linfocitos T, Revistas núcleo. Publicado en: . 
– Three tissue resident macrophage subsets coexist across organs with conserved origins and life cycles
– CD116+ fetal precursors migrate to the perinatal lung and give rise to human alveolar macrophages
– The impact of the lung environment on macrophage development, activation and function: diversity in the face of adversity
En la sección: Avances, Inmunidad de mucosas, Inmunidad innata, Inmunología básica. Publicado en: .
– Fleites YA, Aguiar J, Cinza Z, Bequet M, Marrero E, Vizcaíno M, et al. HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis. Euroasian J Hepatogastroenterol. 2021 Jul-Dec;11(2):59–70.
– Guinovart-Sanjuán D, Guinovart-Díaz R, Vajravelu K, Morales-Lezca W, Abelló-Ugalde I. Multi-population analysis of the Cuban SARS-CoV-2 epidemic transmission before and during the vaccination process. Phys Fluids. 2021 Oct;33(10):107107.
– Lobaina Y, Urquiza D, Garay H, Perera Y, Yang K. Evaluation of Cell-Penetrating Peptides as Mucosal Immune Enhancers for Nasal Vaccination. Int J Pept Res Ther. 2021 Oct 13:1–10.
– Rodríguez-Rodríguez N, Martínez-Jiménez I, García-Ojalvo A, Mendoza-Marí Y, Guillén-Nieto G, Armstrong DG, et al. Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients. MEDICC Review, 2021; https://doi.org/10.37757/MR2021.V23.N3.8.
En la sección: Autores cubanos en revistas extranjeras, COVID-19, Inmunidad de mucosas, Vacunología. Publicado en: .
– Having SARS-CoV-2 once confers much greater immunity than a vaccine—but vaccination remains vital
– Israel’s COVID-19 boosters are preventing infections, new studies suggest
– Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
– Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
– Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection
– SARS-CoV-2 Vaccines: Where Are We Now?
En la sección: COVID-19, Infectología, Inmunidad de mucosas, Vacunología. Publicado en: .
